Zogenix Inc (NASDAQ:ZGNX) Shares Shorted Strengthened By 1.5%

June 29, 2018 - By Julia Strobel

Zogenix, Inc. (NASDAQ:ZGNX) Corporate Logo

Zogenix Inc (NASDAQ:ZGNX) had an increase of its shares shorted by 1.5%. In June was published ZGNX’s total 4.37M shares shorted by FINRA. The up change of 1.5% from 4.31M shares was reported. Former ZGNX’s position will need 10 days to recover. It has 461,100 average volume. Zogenix Inc’s shares shorted float is 15.63%.

The stock increased 1.97% or $0.85 during the last trading session, touching $44.1.Zogenix, Inc. has volume of 402,807 shares. Since June 29, 2017 ZGNX has risen 225.58% and is uptrending. ZGNX outperformed by 213.01% the S&P 500.

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States.The firm is worth $1.55 billion. The companyÂ’s lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome.Currently it has negative earnings. It also develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older.

There’s an important Zogenix, Inc. (NASDAQ:ZGNX) news announced by Investorplace.com. It’s an article titled: “Here’s the Reason that GWPH Stock Tumbled Despite Regulatory Victory” on June 27, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: